Skip to main content
. 2021 Nov 20;46(3):544–554. doi: 10.1038/s41366-021-01022-x

Table 4.

Pooled fixed effect estimates for blood pressure (n = 298).

Systolic blood pressure [mmHg] Diastolic blood pressure
[mmHg]
B 95% CI B 95% CI
Intercept (PRE-POST) 130.91*** [125.01, 136.80] 84.90*** [81.83, 87.96]
Main effects
Group
PRE-POST (ref.)
PRE-PRE 1.31 [−4.41, 7.03] 1.10 [−2.07, 4.27]
POST-POST −1.97 [−6.79, 2.85] 0.01 [−2.66, 2.68]
ACC-MAD [10 mg] 0.28 [−1.42, 2.00] −0.36 [−1.24, 0.51]
Age at baseline [year] 1.10 [−0.03, 2.23] 0.42 [−0.22, 1.06]
Use of hormonal preparations
Non-user (ref.)
Progestogen 0.46 [−2.66, 3.59] −0.18 [−1.80, 1.43]
Estrogen 1.76 [−6.24, 9.76] −0.95 [−4.91, 3.01]
Progestogen + Estrogen −5.55** [−9.61, −1.49] −4.33*** [−6.36, −2.30]
Time (PRE-POST) 9.37** [3.34, 15.39] −0.16 [−3.11, 2.79]
Interactions
Time × Group
Time × PRE-POST (ref.)
Time × PRE-PRE 0.62 [−3.67, 4.91] −0.81 [−2.88, 1.26]
Time × POST-POST −0.03 [−3.80, 3.73] −0.73 [−2.57, 1.12]
Time × ACC-MAD −2.40* [−4.34, −0.46] −0.28 [−1.24, 0.68]

CI Confidence interval, PRE-POST participants who were pre- or perimenopausal at baseline and postmenopausal at follow-up (reference group), PRE-PRE participants who were pre- or perimenopausal in both measurements, POST-POST participants who were postmenopausal already at baseline, ACC-MAD accelerometer-measured mean amplitude deviation, mg milligravity (0.00981 m/s2), Time from baseline to follow-up.

*p ≤ 0.05; **p ≤ 0.01, ***p < 0.001.